| 000 | 00917 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250512093210.0 | ||
| 264 | 0 | _c19700102 | |
| 008 | 197001s 0 0 eng d | ||
| 022 | _a0140-6736 | ||
| 024 | 7 |
_a10.1016/s0140-6736(69)92532-x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFearnley, G R | |
| 245 | 0 | 0 |
_aPhenformin and ethyloestrenol for Raynaud's disease. _h[electronic resource] |
| 260 |
_bLancet (London, England) _cNov 1969 |
||
| 300 |
_a1203 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 |
_aEthylestrenol _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPhenformin _xtherapeutic use |
| 650 | 0 | 4 |
_aRaynaud Disease _xdrug therapy |
| 700 | 1 | _aChakrabarti, R | |
| 773 | 0 |
_tLancet (London, England) _gvol. 2 _gno. 7631 _gp. 1203 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0140-6736(69)92532-x _zAvailable from publisher's website |
| 999 |
_c4192618 _d4192618 |
||